Shandong Buchang Pharmaceuticals Co Ltd (603858) - Total Liabilities
Based on the latest financial reports, Shandong Buchang Pharmaceuticals Co Ltd (603858) has total liabilities worth CN¥9.50 Billion CNY (≈ $1.39 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603858 cash flow metrics to assess how effectively this company generates cash.
Shandong Buchang Pharmaceuticals Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Shandong Buchang Pharmaceuticals Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 603858 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Shandong Buchang Pharmaceuticals Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Buchang Pharmaceuticals Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aya Gold & Silver Inc
TO:AYA
|
Canada | CA$188.27 Million |
|
OneSpaWorld Holdings Ltd
NASDAQ:OSW
|
USA | $164.52 Million |
|
Guangdong Feinan Resources Recycling Co Ltd
SHE:301500
|
China | CN¥7.84 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥562.18 Million |
|
Jones Tech PLC Class A
SHE:300684
|
China | CN¥532.64 Million |
|
Wuxi Nce Power Co Ltd
SHG:605111
|
China | CN¥438.07 Million |
|
GavYam Lands Corp Ltd
TA:GVYM
|
Israel | ILA12.32 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Shandong Buchang Pharmaceuticals Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Buchang Pharmaceuticals Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Buchang Pharmaceuticals Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below shows the annual total liabilities of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥9.52 Billion ≈ $1.39 Billion |
+0.04% |
| 2023-12-31 | CN¥9.52 Billion ≈ $1.39 Billion |
-1.66% |
| 2022-12-31 | CN¥9.68 Billion ≈ $1.42 Billion |
+1.48% |
| 2021-12-31 | CN¥9.54 Billion ≈ $1.40 Billion |
+5.07% |
| 2020-12-31 | CN¥9.08 Billion ≈ $1.33 Billion |
+22.69% |
| 2019-12-31 | CN¥7.40 Billion ≈ $1.08 Billion |
+19.97% |
| 2018-12-31 | CN¥6.17 Billion ≈ $902.29 Million |
+3.15% |
| 2017-12-31 | CN¥5.98 Billion ≈ $874.77 Million |
+0.30% |
| 2016-12-31 | CN¥5.96 Billion ≈ $872.16 Million |
-29.91% |
| 2015-12-31 | CN¥8.50 Billion ≈ $1.24 Billion |
+82.70% |
| 2014-12-31 | CN¥4.65 Billion ≈ $681.06 Million |
+75.26% |
| 2013-12-31 | CN¥2.66 Billion ≈ $388.60 Million |
+61.33% |
| 2012-12-31 | CN¥1.65 Billion ≈ $240.87 Million |
+0.36% |
| 2011-12-31 | CN¥1.64 Billion ≈ $240.00 Million |
-- |
About Shandong Buchang Pharmaceuticals Co Ltd
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.